Role of N6-methyladenosine methyltransferase component RBM15 in cancer progression and its therapeutic potential

Abstract Cancer ranks as a primary cause of mortality globally, and the study of its molecular markers and regulatory mechanisms holds paramount importance. N6-methyladenosine (m⁶A) represents the predominant modification in messenger RNA (mRNA), influencing key biological processes including RNA st...

Full description

Saved in:
Bibliographic Details
Main Authors: Wenxiang Shen, Yulong Ma, Chunwang Yang, Shishun Yan, Kaishan Ye
Format: Article
Language:English
Published: Springer 2025-05-01
Series:Discover Oncology
Subjects:
Online Access:https://doi.org/10.1007/s12672-025-02644-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850140641990803456
author Wenxiang Shen
Yulong Ma
Chunwang Yang
Shishun Yan
Kaishan Ye
author_facet Wenxiang Shen
Yulong Ma
Chunwang Yang
Shishun Yan
Kaishan Ye
author_sort Wenxiang Shen
collection DOAJ
description Abstract Cancer ranks as a primary cause of mortality globally, and the study of its molecular markers and regulatory mechanisms holds paramount importance. N6-methyladenosine (m⁶A) represents the predominant modification in messenger RNA (mRNA), influencing key biological processes including RNA stability, splicing, and translation. The dynamic modulation of m⁶A modification is mediated by an array of enzymes comprising methyltransferases (“writers”), demethylases (“erasers”), and m⁶A-binding proteins (“readers”).As a pivotal member of the m⁶A “writer” family, RNA binding motif protein 15 (RBM15) facilitates the recruitment of the methyltransferase complex (MTC) to mRNA, thus orchestrating the addition of m⁶A modifications. Although prior research has underscored the critical role of m⁶A in oncogenesis, the precise mechanisms through which RBM15 operates in cancer are yet to be elucidated. This study endeavors to elucidate the structural characteristics and functional roles of RBM15, investigate its potential regulatory mechanisms across diverse tumors, uncover its distinct functions in tumor genesis, progression, and metastasis, and evaluate the therapeutic potential of targeting RBM15 in cancer treatment.
format Article
id doaj-art-c16e697c6a3749a4af16ee645c7da7e0
institution OA Journals
issn 2730-6011
language English
publishDate 2025-05-01
publisher Springer
record_format Article
series Discover Oncology
spelling doaj-art-c16e697c6a3749a4af16ee645c7da7e02025-08-20T02:29:45ZengSpringerDiscover Oncology2730-60112025-05-0116112110.1007/s12672-025-02644-7Role of N6-methyladenosine methyltransferase component RBM15 in cancer progression and its therapeutic potentialWenxiang Shen0Yulong Ma1Chunwang Yang2Shishun Yan3Kaishan Ye4Department of Orthopedics, Second Hospital of Lanzhou UniversityDepartment of Orthopedics, Second Hospital of Lanzhou UniversityDepartment of Orthopedics, Second Hospital of Lanzhou UniversityDepartment of Orthopedics, Second Hospital of Lanzhou UniversityDepartment of Orthopedics, Second Hospital of Lanzhou UniversityAbstract Cancer ranks as a primary cause of mortality globally, and the study of its molecular markers and regulatory mechanisms holds paramount importance. N6-methyladenosine (m⁶A) represents the predominant modification in messenger RNA (mRNA), influencing key biological processes including RNA stability, splicing, and translation. The dynamic modulation of m⁶A modification is mediated by an array of enzymes comprising methyltransferases (“writers”), demethylases (“erasers”), and m⁶A-binding proteins (“readers”).As a pivotal member of the m⁶A “writer” family, RNA binding motif protein 15 (RBM15) facilitates the recruitment of the methyltransferase complex (MTC) to mRNA, thus orchestrating the addition of m⁶A modifications. Although prior research has underscored the critical role of m⁶A in oncogenesis, the precise mechanisms through which RBM15 operates in cancer are yet to be elucidated. This study endeavors to elucidate the structural characteristics and functional roles of RBM15, investigate its potential regulatory mechanisms across diverse tumors, uncover its distinct functions in tumor genesis, progression, and metastasis, and evaluate the therapeutic potential of targeting RBM15 in cancer treatment.https://doi.org/10.1007/s12672-025-02644-7RBM15m⁶AOncogenesisTherapeutic targetsMolecular regulation
spellingShingle Wenxiang Shen
Yulong Ma
Chunwang Yang
Shishun Yan
Kaishan Ye
Role of N6-methyladenosine methyltransferase component RBM15 in cancer progression and its therapeutic potential
Discover Oncology
RBM15
m⁶A
Oncogenesis
Therapeutic targets
Molecular regulation
title Role of N6-methyladenosine methyltransferase component RBM15 in cancer progression and its therapeutic potential
title_full Role of N6-methyladenosine methyltransferase component RBM15 in cancer progression and its therapeutic potential
title_fullStr Role of N6-methyladenosine methyltransferase component RBM15 in cancer progression and its therapeutic potential
title_full_unstemmed Role of N6-methyladenosine methyltransferase component RBM15 in cancer progression and its therapeutic potential
title_short Role of N6-methyladenosine methyltransferase component RBM15 in cancer progression and its therapeutic potential
title_sort role of n6 methyladenosine methyltransferase component rbm15 in cancer progression and its therapeutic potential
topic RBM15
m⁶A
Oncogenesis
Therapeutic targets
Molecular regulation
url https://doi.org/10.1007/s12672-025-02644-7
work_keys_str_mv AT wenxiangshen roleofn6methyladenosinemethyltransferasecomponentrbm15incancerprogressionanditstherapeuticpotential
AT yulongma roleofn6methyladenosinemethyltransferasecomponentrbm15incancerprogressionanditstherapeuticpotential
AT chunwangyang roleofn6methyladenosinemethyltransferasecomponentrbm15incancerprogressionanditstherapeuticpotential
AT shishunyan roleofn6methyladenosinemethyltransferasecomponentrbm15incancerprogressionanditstherapeuticpotential
AT kaishanye roleofn6methyladenosinemethyltransferasecomponentrbm15incancerprogressionanditstherapeuticpotential